What if we found cancer early enough to make a difference?

Priority Health is excited to provide access to the Galleri® multi-cancer early detection test from GRAIL. The test is available, for a copay, to PriorityMedicareSM Thrive and PriorityMedicareSM Thrive Plus members that meet the eligibility requirements.

The Galleri test is a proactive blood test that screens for many deadly cancers before symptoms appear.1,2,3 It screens for a “fingerprint” of 50+ cancers including many without recommended screening available today.1

Check Eligibility and Request the Test

Galleri is available by prescription only. The Galleri test does not detect a signal for all cancers, and false positive or false negative results can occur. The Galleri test should be used in addition to healthcare provider recommended screening tests.

Roger testimonial

Galleri is available by prescription only. The Galleri test does not detect a signal for all cancers, and false positive or false negative results can occur. The Galleri test should be used in addition to healthcare provider recommended screening tests.

Who is eligible?

The Galleri test is available to eligible Priority Health Medicare Advantage members* who meet the eligibility requirements. The Galleri test is available by prescription only. 

Eligibility requirements:

  • Individuals 65 years or older who are actively enrolled in one of the following Priority Health Medicare plans:
     
    • PriorityMedicare Thrive - $150 copay (a value of $799)
    • PriorityMedicare Thrive Plus - $75 copay (a value of $874)
  • Not currently undergoing active cancer treatment, though history of cancer^ with treatments completed at least 3 years ago is permitted

* Eligible members can request the Galleri test once every two years.

^ excludes basal or squamous cell carcinoma of the skin

Request the Galleri test

Important – For this program, the Galleri test cost is included as part of your copay if you request the test from a licensed healthcare provider. The Galleri blood draw is also included with your copay if it is completed with a GRAIL partner laboratory (i.e. Quest, ExamOne, etc.). If you choose to complete the blood draw at another lab or office, you will be responsible for the blood draw fee. This program does not cover or pay for follow-up consults and diagnostic procedures (e.g., imaging, biopsies, other laboratory tests, etc.) that your healthcare provider may recommend for you in the event of a “Cancer Signal Detected” Galleri test result. You may incur cost-share expenses such as copays, deductibles, coinsurance. Please contact your health insurer to determine covered expenses and your potential costs related to follow-up procedures that your provider may recommend.

Black couple sitting at their kitchen table writing on a notepad with a cup of coffee and a tablet on the table in front of them

There are two ways to request the Galleri® test

The Galleri test is available by prescription only and must be ordered by a healthcare provider. You can request the test through your healthcare provider or online through an independent telemedicine provider.

Talk to your healthcare provider

At your next wellness visit, ask your healthcare provider about Galleri. Our discussion guide can help start the conversation.

Download Discussion Guide
OR

Request the test online

 

You can also request the Galleri test online through an independent telemedicine provider.

Want your own healthcare provider to order the test for you? 

Access our Patient-Provider Discussion Guide. The Guide has all the information your provider will need to prescribe the test for you. Please print it and bring it along with you to your next scheduled visit. 

Use the form to share your provider information. A GRAIL representative, from the company that makes the Galleri test, will use the information to contact your healthcare provider and offer additional details and support with ordering the test.

Quick tip: Do you use a patient portal to send communications to your healthcare provider? If so, consider uploading and sending them the discussion guide ahead of time. We've provided a short script below to help get the conversation started. 

 

You can use this script as a start a conversation with your provider:

Hello,

I'm considering requesting the Galleri multi-cancer early detection test as part of a covered benefit offered by my employer. It is important to me to discuss this with you as a valued part of my healthcare team.
I've attached a copy of the Galleri Patient-Provider Discussion Guide for your review and will bring a copy to my next appointment. I look forward to discussing this with you soon.

Our testing process

illustrated graphic of a Black male doctor in a white lab coat reading a chart

Request the test

The Galleri test is available by prescription only. Your healthcare provider can order the test, or you can request it through our website from an independent telemedicine provider.

illustrated graphic of the Galleri test box sitting on a table in front of a window

Receive a collection kit

A healthcare provider will review your request, confirm your eligibility,
and order the test if appropriate. You can schedule a blood draw at a GRAIL blood draw partner and we will ship you a Galleri collection kit for your
appointment.

illustrated graphic of a white, gray haired female patient having her blood drawn

Provide your sample

Complete your blood draw at your doctor’s office OR Schedule your blood draw with one of our partners. There are two options: 

1. Have a trained technician come to you. 
2. Visit a partner lab location near you.

Illustrated graphic of a black man sitting in a blue armchair and reviewing test results on a tablet

Receive your results

Your test result will be available about two weeks after your sample is received at the GRAIL lab. Your test result will be shared with you by the provider that ordered the test for you.

Important – For this program, the Galleri test cost is included as part of your copay if you request the test from a licensed healthcare provider. 

The Galleri blood draw is also included with your copay if it is completed with a GRAIL partner laboratory (i.e. Quest, ExamOne, etc.). If you choose to complete the blood draw at another lab or office, you will be responsible for the blood draw fee.

This program does not cover or pay for follow-up consults and diagnostic procedures (e.g., imaging, biopsies, other laboratory tests, etc.) that your healthcare provider may recommend for you in the event of a “Cancer Signal Detected” Galleri test result. You may incur cost-share expenses such as copays, deductibles, and coinsurance. Please contact your health insurer to determine covered expenses and your potential costs related to follow-up procedures that your provider may recommend.

Cancer screening with Galleri can make a difference

Galleri looks for many deadly cancers before symptoms appear from a single blood draw and identifies a unique “fingerprint” of 50+ cancers, including many without a recommended screening available today.
1 / 12

What do Galleri test results mean?


What does a “Cancer Signal Detected” result mean?


The Galleri test looked for a cancer signal in your blood sample and found one. About 1 out of every 100 tests has a Cancer Signal Detected result.4*

This result also include one or two predictions of the tissue type or organ associated with the cancer signal, called "Cancer Signal Origin."

In a clinical study, around 4 out of 10 people with this result were diagnosed with cancer after diagnostic testing.4

*In the PATHFINDER study2, out of 6,578 participants tested with Galleri, 58 had a Cancer Signal Detected result.
 

cancer signal origin image

Other: Anus, Bone and Soft Tissue, Head and Neck, Lymphoid Lineage, Melanocytic Lineage, Myeloid Lineage, Neuroendocrine Cells of Lung or other Organs, Plasma Cell Lineage, Thyroid Gland, Uterus.

Cancer signal detected thumb
NEXT STEPS

A Cancer Signal Detected test result is not a cancer diagnosis and requires follow-up diagnostic testing which may include lab work or imaging ordered by your healthcare provider to confirm cancer.

What does a “No Cancer Signal Detected” result mean?


The Galleri test looked for a cancer signal in your blood sample and did not find one.

In a clinical study, less than 2% of individuals with a No Cancer Signal Detected result had cancer.1,4
 

This result does not completely rule out the possibility of cancer. The Galleri test does not detect a signal for all cancers and not all cancers can be detected in the blood. This result does not predict whether you will develop cancer in the future.

Cancer signal not detected thumb
NEXT STEPS

Continue with any routine cancer screenings your healthcare provider recommends. Do not ignore cancer signs or symptoms if they occur as this could lead to a delayed diagnosis.

The Galleri test does not detect a signal for all cancers, and false positive or false negative results can occur.

Please note - there is a copay to access the test. The Galleri test is available by prescription only. This program does not cover or pay for follow-up consults and diagnostic procedures (e.g., imaging, biopsies, other laboratory tests, etc.) that your healthcare provider may recommend for you in the event of a “Cancer Signal Detected” Galleri test result. You may incur cost-share expenses such as copays, deductibles, and coinsurance. Please contact your health insurer to determine covered expenses and your potential costs related to follow-up procedures that your provider may recommend.

Frequently Asked Questions for Priority Health 

Additional Frequently Asked Questions about the Galleri test

The Galleri test is available to eligible Priority Health Medicare Advantage members* who meet the eligibility requirements. The Galleri test is available by prescription only.

Eligibility Requirements:

  • Individuals 65 years or older who are actively enrolled in one of the following 2025 Priority Health Medicare plans:
     
    • PriorityMedicare Thrive - $150 copay (a value of $799)
    • PriorityMedicare Thrive Plus - $75 copay (a value of $874)
  • Not currently undergoing active cancer treatment, though history of cancer^ with treatments completed at least 3 years ago is permitted

* Eligible members can request the Galleri test once every two years.
^ excludes basal or squamous cell carcinoma of the skin

To access the Galleri test as a covered benefit, you can either request the test through your primary care physician or through this website. 

Order from your primary care physician

Request the test directly from this webpage. An independent telemedicine provider from Recuro Health will review your request and order the test, if appropriate. The test is available by prescription only. 

Individuals 65 years or older who are actively enrolled in one of the following 2025 Priority Health Medicare plans:

  • PriorityMedicare Thrive - $150 copay
    (a value of $799)
  • PriorityMedicare Thrive Plus - $75 copay
    (a value of $874)

Yes, if you have a history of cancer, you may be eligible for the Galleri test. You must not currently be receiving active cancer treatment and you must have completed cancer treatment at least 3 years ago.*


*excludes basal or squamous cell carcinoma of the skin

Under this program, eligible members can request the Galleri test once every two years.

Yes. To order the test through your primary care physician, fill out the form here to download and print the physician guide to bring with you to your appointment. 

Under this program, eligible members can request the Galleri test once every two years.

Get support

For questions about the Galleri test, please contact GRAIL Customer Service:

By email: customerservice@grail.com

By telephone: 1-877-GRAILPH (1-877-472-4574)

The Galleri test is recommended for use in adults with an elevated risk for cancer, such as those age 50 or older. The test does not detect all cancers and should be used in addition to routine cancer screening tests recommended by a healthcare provider. The Galleri test is intended to detect cancer signals and predict where in the body the cancer signal is located. Use of the test is not recommended in individuals who are pregnant, 21 years old or younger, or undergoing active cancer treatment.

Results should be interpreted by a healthcare provider in the context of medical history, clinical signs, and symptoms. A test result of No Cancer Signal Detected does not rule out cancer. A test result of Cancer Signal Detected requires confirmatory diagnostic evaluation by medically established procedures (e.g., imaging) to confirm cancer.

If cancer is not confirmed with further testing, it could mean that cancer is not present or testing was insufficient to detect cancer, including due to the cancer being located in a different part of the body. False positive (a cancer signal detected when cancer is not present) and false negative (a cancer signal not detected when cancer is present) test results do occur. Rx only.

The GRAIL clinical laboratory is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) and accredited by the College of American Pathologists. The Galleri test was developed — and its performance characteristics were determined — by GRAIL. The Galleri test has not been cleared or approved by the Food and Drug Administration. The GRAIL clinical laboratory is regulated under CLIA to perform high-complexity testing. The Galleri test is intended for clinical purposes

  1. American Cancer Society. Cancer facts & figures 2022. https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/cancer-facts-figures-2022.html [GRAIL, LLC. Data on file: GA-2021-0065]
  2. Klein EA, Richards D, Cohn A, et al. Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set. Ann Oncol. 2021;32(9):1167-77. DOI: https://doi.org/10.1016/j.annonc.2021.05.806.
  3. Schrag D, Beer TM, McDonnell CH, et al. Blood-based tests for multi-cancer early detection (PATHFINDER): a prospective cohort study. Lancet. 2023;402:1251-1260. doi:10.1016/S0140-6736(23)01700-2
  4. The Galleri test does not detect all cancers nor does it measure your genetic risk of developing cancer in the future. It should be used in addition to routine screening tests your healthcare provider recommends.